What We Do

Regulatory Roadmap

Deep Science biotech startups have long product life cycles and have to cross several regulatory hurdles. With its inhouse expertise combined with extensive networks, Impres helps the startups clear the hurdle in the most efficient way possible.

Go To Market

Go to market strategy is the most crucial component of any business and much more so for biotech startups. Our ecosystem access includes one of the largest pan India supply chain systems as well as several international partners

Funding

Funding is a very important piece in this puzzle and we understand that. Beyond providing seed capital, Impres has an extensive network of family owned offices and global VC funds which can be leveraged for scale.

Co-creation

We work through an iterative process of co-creation with the founders to help them create a scalable, sustainable business model for their company

Accelerate Globally

Technologies developed by deep science biotech startups generally address a global market. With extensive connects in USA, Europe, Japan and Singapore, Impres makes the prospect of addressing a global market a real possibility.

Indian Launch Pad

Impres' also acts as a "Launch Pad" for global biotech companies which want to access Indian markets. As a first step, Impres along with its partners is building a physical biotech ecosystem which will act as a "Step up Incubator" for such global companies.

.

Meet our team

Prof. Ram Subramanian

Scientific Advisory Board

Institution builder, Currently Director of Bindley Bioscience Center, Discovery Park, Purdue University. Former CEO and Co-founder of CCAMP. Founding Dean of inStem, Bangalore.

Prof. ‪Robert Deschenes‬

Scientific Advisory Board

Professor and Chair, Dept. of Molecular Medicine, Morsani College of Medicine, University of South Florida; Sr. Associate Dean of Research and Graduate Education, USF ;
Member, American Association of Advancement of Science (AAAS)

Ashok Vohra

Director

Founder of Evoma, an ecosystem designed for business incubation and for entry of organizations into India. Former chairman of Esco Singapore a systems integration company with operating infrastructure in most Asia Pacific countries including Japan

Hiitesh Toppiwaala

Director

Managing Director at Paramount Cosmetics India Ltd., a publicly traded company with national presence. Extensive experience in setting up and managing distribution networks.

Anand AnandKumar

Mentor

Serial Entrepreneur, CEO of Bugworks. 28 years experience in industry spanning Semiconductor to Biopharmaceuticals. Founder of Cellworks, Former MD of Spincircuit and Magma India, both of which got acquired by large enterprises.

Jogin Desai

Director

Dr. Jogin Desai is a doctor-manager, currently Co-founder of Eyestem. Prior to Eyestem, he was part of the global leadership team at Quintiles and headed cardiac safety business. More recently, he was the CEO of Cenduit, the world’s largest standalone randomization company which is a joint venture of Quintiles and ThermoFisher Scientific.

Nitish Sathyanarayanan

Science Officer

Was awarded the prestigious Prime Minister’s Fellowship to undertake graduate research at inStem, in collaboration with CII and Evolva (a swiss synthetic biology company). 7+ years of training in biochemistry and genomics with 15+ research publications.

Our Portfolios

Contact Us

hello@impreshealth.com